周五，美银美林证券调整了对Ardent Health Partners Inc（NYSE:ARDT）的展望，将目标价从21.00美元下调至19.00美元，同时维持对该公司股票的"优于大市"评级。该股目前交易价格为13.26美元，接近其52周低点13.21美元，已有五位分析师下调了其盈利预期。此次调整是由于公司今年早些时候发布的指引变化，该指引将此前未宣布的并购从公司战略考虑中排除。

A struggling Central Florida mall has found a buyer with a vision for its future. Learn about the multimillion-dollar deal ...

The Ardent Companies, a privately held real estate firm based in Atlanta, has closed on a deal for the 76-acre site in Sanford for $17 million.

周二，RBC Capital Markets调整了对Ardent Health Partners ...

Ardent Health Partners, Inc. (NYSE: ARDT) (“Ardent Health” or the “Company”), a leading provider of healthcare in growing mid ...

Ardent Health Partners, Inc. (NYSE:ARDT) just released its latest full-year results and things are looking bullish. It was overall a positive result, with revenues beating expectations by 2.1% to hit ...

Excluding that benefit, which was not included in previous guidance, Ardent Health delivered financial and operating performance that was consistent or favorable to our 2024 guidance." ...